Dr. John Norman is a partner and litigator in the Ottawa office of Gowling WLG, serving as head of the firm’s Life Sciences Group and practising in its Intellectual Property Group. He helps Canadian and international clients protect and manage their patent and intellectual property portfolios and develop effective litigation strategies. John represents a wide range of clients, including leading national and international innovation companies primarily in the pharmaceutical, biotechnology, and technology sectors. He advises on pharmaceutical regulation and patent litigation, including patent infringement actions, patent impeachment actions, and proceedings under the Patented Medicine (Notice of Compliance) Regulations and before the Patented Medicine Prices Review Board. John also regularly appears before the Federal Court of Canada, the Federal Court of Appeal, and the SCC. He serves on the Board of Directors of BIOTECanada and is a member of the organization’s committee dealing with follow-on biologics and biosimilars. He is a frequent speaker and writer on pharmaceutical and technology patent litigation matters. Prior to joining the firm, John obtained a PhD in biochemistry from the Faculty of Medicine at Dalhousie University.
Year Called to the Bar: